flow trial glp 1 Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetic weight loss, they REDUCE risk of cardiovascular death, all cause mortality, and now, progression of kidney disease! Just published Effects of semaglutide with and

GLP-1 medications have made weight loss easier to access than ever, but not all options are created equal

Kathy Bates It was hard work

A handful of reports do exist in post-marketing surveillance through the FDA Adverse Event Reporting System, but the post says their causal relationship to the medication remains unclear rather than established

Well help avoid overlap, reduce risk of hypoglycemia, and integrate with your current regimen smartly

In research models, it's shown impressive regenerative effects: But and this is important most of this data comes from animal studies or anecdotal human use, not large-scale clinical trials